FinTrust Capital Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
FinTrust Capital Advisors's DGX Position: Q3 2024 in Review
FinTrust Capital Advisors increased its Quest Diagnostics (DGX) stake by 837% in Q3 2024, buying an estimated $85K and bringing the position to 637 shares worth $98.9K. The position accounts for 0.02% of the portfolio, ranked #439.
FinTrust Capital Advisors first reported a position in DGX in Q4 2018 and has held it in 24 quarters since. 847 funds tracked by Wall St. Rank hold DGX as of Q3 2024.
- FinTrust Capital Advisors held 637 shares of Quest Diagnostics worth $98.9K as of Q3 2024.
- FinTrust Capital Advisors bought 569 Quest Diagnostics shares in Q3 2024, an estimated $85K.
- Quest Diagnostics made up 0.02% of FinTrust Capital Advisors's portfolio in Q3 2024, its #439 holding.
- FinTrust Capital Advisors first reported a position in Quest Diagnostics in Q4 2018 and has held it in 24 quarters since.
- 847 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.
Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.